H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other… Read more
H&R GmbH & Co. KGaA (2HRA) - Total Liabilities
Latest total liabilities as of September 2025: €531.54 Million EUR
Based on the latest financial reports, H&R GmbH & Co. KGaA (2HRA) has total liabilities worth €531.54 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
H&R GmbH & Co. KGaA - Total Liabilities Trend (2002–2024)
This chart illustrates how H&R GmbH & Co. KGaA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
H&R GmbH & Co. KGaA Competitors by Total Liabilities
The table below lists competitors of H&R GmbH & Co. KGaA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PharmGen Science Inc
KO:004720
|
Korea | ₩83.70 Billion |
|
5paisa Capital Ltd
NSE:5PAISA
|
India | ₹12.18 Billion |
|
BioNxt Solutions Inc.
OTCQB:BNXTF
|
USA | $9.54 Million |
|
Ditas Dogan Yedek Parca Imalat ve Teknik AS
IS:DITAS
|
Turkey | TL2.20 Billion |
|
Vittia Fertilizantes
SA:VITT3
|
Brazil | R$312.37 Million |
|
Trk Corp
TW:1432
|
Taiwan | NT$4.36 Billion |
|
GenoFocus Inc
KQ:187420
|
Korea | ₩88.25 Billion |
|
Cardlytics Inc
NASDAQ:CDLX
|
USA | $297.51 Million |
Liability Composition Analysis (2002–2024)
This chart breaks down H&R GmbH & Co. KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.22 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how H&R GmbH & Co. KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for H&R GmbH & Co. KGaA (2002–2024)
The table below shows the annual total liabilities of H&R GmbH & Co. KGaA from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €546.26 Million | +22.58% |
| 2023-12-31 | €445.62 Million | -9.23% |
| 2022-12-31 | €490.91 Million | +5.37% |
| 2021-12-31 | €465.90 Million | +16.82% |
| 2020-12-31 | €398.83 Million | -16.06% |
| 2019-12-31 | €475.15 Million | +27.37% |
| 2018-12-31 | €373.03 Million | +16.62% |
| 2017-12-31 | €319.87 Million | -3.29% |
| 2016-12-31 | €330.75 Million | -3.18% |
| 2015-12-31 | €341.63 Million | -25.36% |
| 2014-12-31 | €457.71 Million | +12.88% |
| 2013-12-31 | €405.49 Million | +1.80% |
| 2012-12-31 | €398.34 Million | +1.10% |
| 2011-12-31 | €394.02 Million | +28.80% |
| 2010-12-31 | €305.92 Million | +8.99% |
| 2009-12-31 | €280.68 Million | +5.08% |
| 2008-12-31 | €267.12 Million | +14.29% |
| 2007-12-31 | €233.72 Million | -21.13% |
| 2006-12-31 | €296.36 Million | -1.50% |
| 2005-12-31 | €300.86 Million | +22.80% |
| 2004-12-31 | €245.01 Million | +189.56% |
| 2003-12-31 | €84.61 Million | +29.48% |
| 2002-12-31 | €65.35 Million | -- |